• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » CB Insights reports digital health, global healthcare investment funding records

CB Insights reports digital health, global healthcare investment funding records

October 20, 2020 By Sean Whooley

CB Insights reported record funding for global healthcare and digital health, among other milestones during the third quarter.

Global healthcare investments to private companies hit a new quarterly record of $21.8 billion in the third quarter of this year, with a total of 1,539 equity investments in the three-month period growing 18% from the previous quarter. North American companies raised almost $13 billion in the quarter, marking the highest total on record and a 21% increase from the previous quarter.

Digital health, which was thrust into the fore because of its relevance during the COVID-19 pandemic, grew in equity funding by 73% to reach $8.4 billion in the third quarter, which is another record. An all-time high of 23 mega-rounds played a large part in that, according to the analysis.

However, New York saw a 20% decline in digital health deal activity, with Massachusetts growing by 33% and California increasing by 12% in that space.

Medical devices also hit a quarterly high during the three-month period, with medical device companies raising $5 billion over 478 deals, marking a 20% jump from last quarter and a new quarterly high, while it’s a whopping 63% growth year-over-year.

Amid the race to develop vaccines and therapeutics for COVID-19, drug research & development funding saw 38 deals in the quarter, with nearly $1.5 billion in financing driven by five mega-rounds over the three months.

The quarter saw 38 deals and nearly $1.5B in funding to the space. This funding total was largely driven by 5 mega-rounds, including AI drug discovery company XtalPi’s $319M round and clinical research platform Taimei Technology’s $176M round.

Analysts highlighted robotic surgery as a space that continued to raise capital despite the deferral of elective procedures that has been brought on by the pandemic, while novel neuromodulation devices also received a mention for gaining steam with investments and clinical milestones.

Medtronic’s dealings over the last quarter were another major highlight, according to analysts, with big plays in the diabetes and neurosurgery markets. The medtech giant’s acquisition of Medicrea was highlighted, as was the announcement of its intention to acquire insulin pen maker Companion Medical.

Filed Under: Business/Financial News, Diabetes, Digital Health, Emerging Markets, Featured, Funding Roundup, Health Information Technology, Mergers & Acquisitions, Neurological, Neuromodulation/Neurostimulation, Research & Development, Software / IT, Surgical, Surgical Robotics, Wall Street Beat Tagged With: CB Insights, coronavirus, COVID-19, Medtronic

More recent news

  • Ambu wins FDA clearance for first single-use cysto-nephroscope
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy